Condition: Acute Myeloid Leukemia · Sponsor: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
The VERDI study is an investigator-initiated, multicenter, multicohort, phase II trial with combination of venetoclax + azacitidine for patients treated for AML under according to an intensive chemotherapy protocol (CETLAM-20) failing to achieve or maintain MRD negativity at pre-established time-points: at chemotherapy completion for ELN favorable subtypes, and prior to alloHCT for non-favorable European LeukemiaNet (ELN) AML patients. The primary objective is to determine Ven/Aza treatment activity in MRD clearance in patients diagnosed with AML with persistent MRD or MRD reappearance after frontline chemotherapy, or prior to alloHCT.
This description comes directly from the study's public registry record.
A responsible person Designated by the sponsor · 0034934344412 · investigacio@mfar.net
Always discuss trial participation with your own doctor first.
| University Hospital Son Espases | Palma de Mallorca, Balearic Islands, Spain | Recruiting |
| Hospital Son Llatzer | Palma de Mallorca, Balearic Islands, Spain | Recruiting |
| Institut Catala D oncologia Badalona | Badalona, Catalonia, Spain | Recruiting |
| Hospital Del Mar | Barcelona, Catalonia, Spain | Recruiting |
| Hospital De La Santa Creu I Sant Pau | Barcelona, Catalonia, Spain | Recruiting |
| Hospital Universitari Vall D Hebron | Barcelona, Catalonia, Spain | Recruiting |
| Hospital Clinic De Barcelona | Barcelona, Catalonia, Spain | Recruiting |
| Institut Catala D oncologia Girona | Girona, Catalonia, Spain | Recruiting |
| Institut Catala D oncologia Hospitalet | L'Hospitalet de Llobregat, Catalonia, Spain | Recruiting |
| Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida | Lleida, Catalonia, Spain | Recruiting |
| Hospital Universitari Joan XXIII De Tarragona | Tarragona, Catalonia, Spain | Recruiting |
| Fundacio Assistencial De Mutua De Terrassa | Terrassa, Catalonia, Spain | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06668558